Breast cancer stem cell markers CD44 and ALDH1A1 in serum: distribution and prognostic value in patients with primary breast cancer

Conclusion: Serum CD44 was an independent prognostic indicator in primary breast cancer. However, serum ALDH1A1 has no impact on survivals and might not be an appropriate candidate to predict prognosis for breast cancer.

Source: Journal of Cancer - December 14, 2018 Category: Cancer & Oncology Authors: Yanan Kong, Ning Lyu, Jiali Wu, Hailin Tang, Xinhua Xie, Lu Yang, Xing Li, Weidong Wei, Xiaoming Xie Tags: Research Paper Source Type: research